- Business
- ICL Group Ltd ICL Group Ltd manufactures and markets specialty minerals, fertilizers, and chemicals for agriculture, food, and industrial applications worldwide. The company operates through four primary segments—Growing Solutions, Industrial Products, Phosphate Solutions, and Potash—producing potash in standard, granular, fine red, and white forms; phosphates including phosphate rock, phosphoric acid, specialty fertilizers, and animal feed additives; flame retardants such as brominated and organophosphorus compounds; elemental bromine; specialty phosphates like technical, food-grade, and electronic-grade phosphoric acid; phosphate salts; food additives; wildfire safety products; alumina; controlled-release, water-soluble, and slow-release fertilizers; straights such as MAP, MKP, and PeKacid; organic fertilizers; micronutrients; biostimulants; soil conditioners; adjuvants; seed treatments; growing media; functional food ingredients; phosphate additives for processed meat, poultry, seafood, dairy, beverages, and baked goods; mineral-based food-grade supplements like magnesium and calcium from the Dead Sea; health and personal care solutions; energy sector products for e-vehicles, renewables, oil and gas; and anti-microbial solutions for water systems, cooling towers, and paper mills. ICL Group Ltd serves markets in agriculture, food processing, engineered materials, energy, health, and personal care, with production, R&D, and sales operations spanning North America, South America, Europe, Israel, Asia, Australia, and Africa, employing over 13,000 people. Founded in 1968 and headquartered at Millennium Tower, 23 Aranha Street, Tel Aviv-Yafo, Israel, the company, formerly Israel Chemicals Ltd., changed its name in May 2020 and maintains leadership as the world's sixth-largest potash producer and a major bromine supplier. In recent developments, ICL Group Ltd completed the acquisition of most activities of Lavie Bio Ltd and MicroBoost AI from Evogene Ltd in April 2025 for approximately US$18.75 million, enhancing its biologicals portfolio with microbial discovery platforms, biostimulant programs, and AI-driven agriculture tech; earlier in 2024, it acquired Brazilian biologicals firm Nitro 1000 and opened a research center for biologicals in Israel, signaling a strategic expansion into innovative ag solutions amid megatrends in sustainable agriculture and digital farming.